EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 3.33p on 02-07-2026 at 16:15:00 |
|---|---|
| Change | -0.325p -8.89% |
| Buy | 4.00p |
| Sell | 3.355p |
| Last Trade: | Buy 145,431.00 at 3.33p |
| Day's Volume: | 1,838,091 |
| Last Close: | 3.33p |
| Open: | 3.505p |
| ISIN: | GB0033711010 |
| Day's Range | 3.33p - 3.52p |
| 52wk Range: | 1.40p - 19.00p |
| Market Capitalisation: | £20.78m |
| VWAP: | 3.449372p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 145,431 | 3.33p | Suspected BUY Trade |
16:35:24 - 02-Jul-26 |
| Sell* | 250,000 | 3.4835p | Ordinary |
16:28:45 - 02-Jul-26 |
| Sell* | 4,090 | 3.355p | Automatic Execution |
16:27:33 - 02-Jul-26 |
| Sell* | 9,981 | 3.4817p | Ordinary |
16:21:29 - 02-Jul-26 |
| Buy* | 2,500 | 3.625p | Ordinary |
16:17:56 - 02-Jul-26 |
| Buy* | 274 | 3.65p | Ordinary |
16:15:40 - 02-Jul-26 |
| Sell* | 40,840 | 3.5018p | Ordinary |
16:13:42 - 02-Jul-26 |
| Buy* | 114 | 3.50p | SI Trade |
16:11:05 - 02-Jul-26 |
| Sell* | 3,615 | 3.35p | SI Trade |
15:56:27 - 02-Jul-26 |
| Sell* | 35,000 | 3.4788p | Ordinary |
15:55:41 - 02-Jul-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |
| 9th Apr 2026 7:00 am | RNS-R | Chairman’s Open Letter to Shareholders |
| 7th Apr 2026 11:45 am | RNS | Result of General Meeting and TVR |